SynthesisJournal for immunotherapy of cancer2017
Evaluation of dosing strategy for pembrolizumab for oncology indications.
Tomoko Freshwater et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
128 papers cite itlatest 60 shown
this paperpooled ittrialcites it